|
⚲
|
| Keyboard |
| Arkin Bio Ventures 2 LP
✚
|
|
|---|---|
| CIK # | 0001858705 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001858705] | |
| 4 | [0001858705] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Werewolf Therapeutics Inc | |
| Arkin Bio Ventures 2 LP | |
| Arkin Bio Ventures GPGP Ltd | |
| Arkin Moshe |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Buy | 400,000 | $16.00 | 6,400,000 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 410,717 | ||
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 1,235,917 | ||
|
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
|
2021-05-04 | Conversion | 3,560,551 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Series A Preferred Stock · derivative
|
2021-05-04 | Conversion | 10,714,284 | $0.00 |